Principal Healthcare Innovators Index ETF (BTEC)

View Results:

Show data:

Fund Prices
(as of ) (as of ) (as of ) (as of )

$ Price $ NAV $ Chg Price $ Chg NAV YTD % (Price)
26.36 26.36 26.79 26.79 0.17 0.17 NA NA 0.17 0.17 NA NA 0.15 0.15 0.17 0.17

Average Annual Total Returns (%)
(as of ) (as of ) (as of ) (as of )

1 yr 3 yr 5 yr 10 yr Since
Incep
Incep
Date
NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 7.23 7.23 7.16 7.16

Fund Expenses

Net
Expense
Gross
Expense
Expense Limit
Expiration
Expense Waiver
Expiration
0.42 0.42 N/A N/A
SEC Yield % Benchmark
0.00  NQHCIN

Morningstar Rating

Category: Health

N/A
126 funds
N/A
119 funds
N/A
96 funds
N/A
126 funds

​Performance data quoted represents past performance. Past performance is no guarantee of future results and investment returns, and principal value of the Fund will fluctuate so that shares, when redeemed, may be worth more or less than their original cost. Current performance may be higher or lower than the performance quoted. Visit principaletfs.com for current month-end performance.

Access to Innovation

Get long-term growth potential from early stage health care innovation: medicines, therapies, and equipment.


Investment Strategy What's This?

The investment seeks to provide investment results that closely correspond, before expenses, to the performance of the Nasdaq Healthcare Innovators Index (the "index"). Under normal circumstances, the fund invests at least 80% of its net assets, plus any borrowings for investment purposes, in equity securities of companies that compose the index at the time of purchase. The index is designed to provide exposure to equity securities (including growth and value stock) of small and medium capitalization U.S. healthcare companies.

Investment Manager or Sub-advisor

Principal Global Investors, LLC

Portfolio Managers

Mark Nebelung
Since
Paul Kim
Since
Jeffrey Schwarte
Since

Premium/Discount to NAV What's This?

Sorry, but there is no data available for this quarter.

This information shows differences between the per share net asset value (NAV) of the Fund and the market trading price of shares. For these purposes, the market price is the midpoint of the highest bid and lowest offer for Fund shares as of close of trading on the exchange where Fund shares are listed. Timing discrepancies may exist between NAV and closing price. Shareholders may pay more than net asset value when they buy Fund shares and receive less than net asset value when they sell those shares, because shares are bought and sold at current market prices.​

Total Returns What's This?


Average Annual Total Returns
as of
1Mo 3Mo YTD 1Yr 3Yr 5Yr 10Yr Since Inception*
Net Asset Value (NAV) Return -0.20 16.66 16.66 NA NA NA NA 7.23
Market Price Return -0.37 16.53 16.53 NA NA NA NA 7.16
NASDAQ US Health Care Innovators Index -0.15 16.82 16.82 NA NA NA NA 7.53
Health -0.12 10.82 10.82 14.39 8.42 16.30 11.22 NA
Morningstar Percentile Rankings NA NA NA NA NA NA NA NA
# of Funds in Category 149 148 148 140 126 119 96 NA
Average Annual Total Returns
as of
1Mo 3Mo YTD 1Yr 3Yr 5Yr 10Yr Since Inception*
Net Asset Value (NAV) Return -0.20 16.66 16.66 NA NA NA NA 7.23
Market Price Return -0.37 16.53 16.53 NA NA NA NA 7.16
NASDAQ US Health Care Innovators Index -0.15 16.82 16.82 NA NA NA NA 7.53
* Inception date: What's This?

Investment results shown represent historical performance and do not guarantee future results. Investment returns and principal values fluctuate with changes in interest rates and other market conditions so the value, when redeemed, may be worth more or less than original costs. Current performance may be lower or higher than the performance data shown.


Where gross and net expense ratios differ, Principal Management Corporation has contractually agreed to limit the investment option's expenses. Differences also may be due to Principal Management Corporation's decision to pay (through the same dates) certain expenses that would normally be payable by the fund. Returns displayed are based on net total investment expense.

Morningstar percentile rankings are based on total returns and do not reflect the inclusion of sales charges. If sales charges were reflected, rankings could be lower.



Calendar Year Total Returns 2016 2015 2014 2013 2012
Net Asset Value (NAV) Return 0.00 0.00 0.00 0.00 0.00
Market Price Return 0.00 0.00 0.00 0.00 0.00
NASDAQ US Health Care Innovators Index 0.00 0.00 0.00 0.00 0.00
Health -10.60 8.05 27.25 48.17 21.55
Morningstar percentile rankings are based on total returns and do not reflect the inclusion of sales charges. If sales charges were reflected, rankings could be lower.

Expenses
as of

Total Investment Expense - Gross:
0.42%
Total Investment Expense - Net:
0.42%
Waiver Date:
NA
Contractual Cap Date:
NA

Distribution History What's This?

Ex-Date
Type
$ Per Share

Dividends are paid quarterly.

Daily Pricing at NAV

Risk and Return Statistics
as of N/A

3 Year
5 Year
Alpha
--
--
Beta
--
--
R-Squared
--
--
Standard Deviation
--
--
Mean
--
--
Sharpe Ratio
--
--
Excess Return
--
--
Tracking Error
--
--
Information Ratio
--
--
Inception Date:

Risk and return statistical data is calculated by Morningstar, Inc. Excess Return is calculated by Principal Life Insurance Company.

Alpha - The difference between an investment's actual returns and its expected performance, given its level of risk (as measured by beta).

Beta - An investment's sensitivity to market movements.

R-Squared - Ranges from 0 to 100 and reveals how closely an investment's returns track those of a benchmark index.

Standard Deviation - Measures how much an investment's returns are likely to fluctuate.

Mean - Represents the annualized total return for a fund over 3 years.

Sharpe Ratio - Measures how an investment balances risks and rewards. The higher the Sharpe ratio, the better the investment's historical risk-adjusted performance.

Excess Return - The difference between an investment option's return and the return of an external standard such as a passive index.

Tracking Error - Also known as "excess risk", is defined as the standard deviation or volatility of excess returns.

Information Ratio - A risk-adjusted measure commonly used to evaluate an active manager's involvement skill. It's defined as the manager's excess return divided by the variability or standard deviation of the excess return.

Morningstar Star Rating™
as of N/A

3 Year
5 Year
Overall
Rating
---
---
---
# Funds
126
119
126
Morningstar Category: Health
What's This?

Morningstar's Star Ratings reflect risk adjusted performance and are derived from a weighted average of the performance figures associated with its three, five, and ten-year (if applicable) time periods.

Portfolio Composition
as of What's This?

Asset Type
Net
Short
Long
U.S. Bonds
0.00%
0.00%
0.00%
Non-U.S. Bonds
0.00%
0.00%
0.00%
U.S. Stocks
99.85%
0.00%
99.85%
Non-U.S. Stocks
0.00%
0.00%
0.00%
Preferred
0.00%
0.00%
0.00%
Other
0.15%
0.00%
0.15%
Cash
0.00%
0.00%
0.00%
Convertibles
0.00%
0.00%
0.00%
Total
100.00%

Top 10 Holdings
as of What's This?

Total Market Value
% of Net Assets
VERTEX PHARMACEUTICALS INC COMMON STOCK USD.01
276,968.12
4.20%
INCYTE CORP COMMON STOCK USD.001
268,872.24
4.08%
SEATTLE GENETICS INC COMMON STOCK USD.001
255,623.52
3.88%
ALKERMES PLC COMMON STOCK USD.01
239,230.41
3.63%
BIOMARIN PHARMACEUTICAL INC COMMON STOCK USD.001
200,851.98
3.05%
TESARO INC COMMON STOCK USD.0001
198,645.29
3.01%
DEXCOM INC COMMON STOCK USD.001
177,226.50
2.69%
PERRIGO CO PLC COMMON STOCK EUR.001
149,008.32
2.26%
IONIS PHARMACEUTICALS INC COMMON STOCK USD.001
144,477.97
2.19%
EXELIXIS INC COMMON STOCK USD.001
136,725.16
2.07%

Includes, but is not limited to, unsettled activity from creation/redemption transactions and portfolio security trades and accrued interest.

Values may exceed 100% if both long and short positions are included in the portfolio

Holdings subject to change​

Stock Sector Breakdown
as of
What's This?

% of Stocks

Cyclical
0.00
Basic Materials
0.00
Consumer Cyclical
0.00
Financial Services
0.00
Real Estate
0.00

Defensive
98.92
Consumer Defensive
0.00
Healthcare
98.92
Utilities
0.00

Sensitive
1.08
Communication Services
0.00
Energy
0.00
Industrials
0.00
Technology
1.08

Morningstar Style Box
as of
What's This?

Investment Style
Value
Blend
Growth
Large
Medium
Small
Market Capitalization

The Morningstar Style Box is a nine-square grid that provides a graphical representation of the "investment style" of stocks and mutual funds. For stocks and stock funds, it classifies securities according to market capitalization (the vertical axis) and growth and value factors (the horizontal axis). Fixed income funds are classified according to credit quality (the vertical axis) and sensitivity to changes in interest rates (the horizontal axis).

Analysis
as of

Average Market Cap (mil):
$3,020.32
Price/Earnings Ratio:
52.96
Price/Book Ratio:
3.81
Price/Cash Flow Ratio:
6.85
Turnover Ratio:
34.30%
# Stock Holdings:
152
# Bond Holdings:
0
# Other Holdings:
1
# Total Holdings:
153

As the Baby Boomer generation ages, we believe they'll demand more and better health care solutions—including new or improved medical devices, pharmaceuticals, and assisted living facilities.

The Principal Healthcare Innovators Index ETF (BTEC) invests in innovative health care companies working to overcome these and other health care challenges.

These are small- to mid-cap companies that are very early in their research and development cycles. They might not even be generating revenue at this point, but we believe they're on their way to becoming leaders in the field.

Find a Fund

Principal Healthcare Innovators Index ETF (BTEC) Overview

Ticker
BTEC

Benchmark
NASDAQ US Health Care Innovators Index
( NQHCIN)


Net Assets
as of
$6,592,983.97

Daily Volume
0

Shares Outstanding
250,001
30 Day SEC Yield
as of
0.00%

30 Day SEC Yield (Unsubsidized)
as of
0.00%

Distribution Yield
as of
--

Number of Holdings
as of
153

Premium/Discount to NAV
-0.04%

Additional Tickers

NAV Per ShareBTEC.NV
Intraday NAVBTEC.IV
Shares OutstandingBTEC.SO
Estimated CashBTEC.EU
Total CashBTEC.TC

Disclosures

Investor shares are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Ordinary brokerage commissions apply.

Returns shown for periods of less than one year are not annualized.

The market price used to calculate the Market Price Return is the midpoint between the highest bid and the lowest offer on the exchange on which the shares of the Fund are listed for trading, as of the time that the Fund's NAV is calculated. If you trade your shares at another time, your return may differ.

The Principal Healthcare Innovators Index ETF seeks to track the Nasdaq U.S. Healthcare Innovators Index, a Nasdaq-licensed index based on Principal’s intellectual property. The Nasdaq U.S. Healthcare Innovators Index is designed to provide exposure to U.S. companies that are early stage healthcare companies.

© 2016 Morningstar, Inc. All Rights Reserved. Part of the mutual fund data contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete, or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.


Performance data quoted represents past performance. Past performance is no guarantee of future results and investment returns, and principal value of the Fund will fluctuate so that shares, when redeemed, may be worth more or less than their original cost. Current performance may be higher or lower than the performance quoted.

Investors should carefully consider a fund’s investment objectives, risks, charges, and expenses prior to investing.

Asset allocation and diversification do not ensure a profit or protect against a loss. Investing in ETFs involves risk, including possible loss of principal. ETFs are subject to risk similar to those of stocks, including those regarding short-selling and margin account maintenance.

Investor shares are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Ordinary brokerage commissions apply.

Returns shown for periods of less than one year are not annualized.

Morningstar Ratings do not reflect the inclusion of sales charges. If sales charges were reflected, rankings could be lower.


Footnotes

Equity investments involve greater risk, including higher volatility, than fixed-income investment options.


Small and mid-cap stocks may have additional risks including greater price volatility.


Investments concentrated in the healthcare industry may be adversely impacted by sector specific market shocks, unforeseen rate controls or regulations, higher than expected costs, or inability to bring new products to market.